Review our expert witness experience in product liability & IP infringement cases

  • Home
  • Regulatory Affairs
    • Regulatory Strategy
    • RA Example Presentations
    • RA Peer Reviewed Pubs
  • Expert Witness Support
  • Recent Support Examples
  • Market Access
    • Market Access Strategy
    • MA Example Presentations
    • MA White Papers
  • Pricing
    • Pricing Strategy
    • Market Research
  • About Us
  • Contact Us
  • More
    • Home
    • Regulatory Affairs
      • Regulatory Strategy
      • RA Example Presentations
      • RA Peer Reviewed Pubs
    • Expert Witness Support
    • Recent Support Examples
    • Market Access
      • Market Access Strategy
      • MA Example Presentations
      • MA White Papers
    • Pricing
      • Pricing Strategy
      • Market Research
    • About Us
    • Contact Us
  • Home
  • Regulatory Affairs
    • Regulatory Strategy
    • RA Example Presentations
    • RA Peer Reviewed Pubs
  • Expert Witness Support
  • Recent Support Examples
  • Market Access
    • Market Access Strategy
    • MA Example Presentations
    • MA White Papers
  • Pricing
    • Pricing Strategy
    • Market Research
  • About Us
  • Contact Us
Colorful DNA strands and genetic sequence data.

The US Food and Drug Administration (FDA) and European Medical Agency
(EMA), as well as other regulatory agencies throughout the globe have product
commercialization requirements that evolve constantly in tandem.with technological advances, as well as public health needs. In the US
market, three evolving areas from FDA’s perspective are the evolution of the 510(k) premarket notification process, regulation of specific rare diseases, and advertising and promotional regulation(s).  tJûn17 Life Sciences Advisors will help you to apply current global regulatory guidelines to maximize your chance for product marketing approvals and to minimize time to peak sales.  In addition, we will support you in your submission of compliant regulatory applications and documentation to global regulators and a wide array of other stakeholders.


Learn More

A product commercialization plan for sustaining unique and superior competitive advantages in today’s global medical technology market starts with a well researched and comprehensive regulatory strategy.

Get Regulatory Support
  • Home
  • Expert Witness Support

tJun17 Life Science Advisors

Copyright © 2026 tJun17 Life Science Advisors - All Rights Reserved.

Powered by

This website uses cookies

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept